Genascence Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$11.6M
- Investors
-
7
Genascence General Information
Description
Developer of genetic therapy designed to provide treatment for rare disorders and tackle major prevalent diseases affecting people. The company's therapy offers the treatment of osteoarthritis disease as well as improves symptoms and reduces structural disease progression in osteoarthritis patients, enabling patients to avail improved medical care and recover quickly.
Contact Information
Website
www.genascence.comCorporate Office
- 350 Cambridge Avenue
- Suite 300
- Palo Alto, CA 94306
- United States
Corporate Office
- 350 Cambridge Avenue
- Suite 300
- Palo Alto, CA 94306
- United States
Genascence Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 23-Feb-2023 | $11.6M | Completed | Clinical Trials - Phase 2 | ||
| 4. Grant | 01-Apr-2022 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC (Series A) | 07-Jan-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Seed Round | 29-Jul-2019 | $470K | $470K | Completed | Clinical Trials - Phase 1 | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Genascence Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Genascence Comparisons
Industry
Financing
Details
Genascence Competitors (23)
One of Genascence’s 23 competitors is Xalud Therapeutics, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xalud Therapeutics | Venture Capital-Backed | New York, NY | ||||
| Alexion | Formerly VC-backed | Boston, MA | ||||
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| Artax Biopharma | Venture Capital-Backed | Cambridge, MA |
Genascence Patents
Genascence Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026080261-A1 | Methods of treating osteoarthritis, and compositions for practicing the same | Pending | 07-Oct-2024 | ||
| EP-4688152-A2 | Methods and compositions for treating osteoarthritis | Pending | 31-Mar-2023 | ||
| US-20260263499-A1 | Methods and compositions for treating osteoarthritis | Pending | 31-Mar-2023 | ||
| WO-2024206333-A2 | Methods and compositions for treating osteoarthritis | Inactive | 31-Mar-2023 | ||
| WO-2024206333-A3 | Methods and compositions for treating osteoarthritis | Inactive | 31-Mar-2023 | C12N15/86 |
Genascence Signals
Genascence Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| California Institute for Regenerative Medicine | Government | |||
| United States Department of War | Government | Minority | ||
| Deepwork Capital | Venture Capital | Minority | ||
| Pacira BioSciences | Corporation | Minority | ||
| University of Florida Research Foundation | Corporation | Minority |
Genascence FAQs
-
When was Genascence founded?
Genascence was founded in 2017.
-
Where is Genascence headquartered?
Genascence is headquartered in Palo Alto, CA.
-
What is the size of Genascence?
Genascence has 5 total employees.
-
What industry is Genascence in?
Genascence’s primary industry is Biotechnology.
-
Is Genascence a private or public company?
Genascence is a Private company.
-
What is Genascence’s current revenue?
The current revenue for Genascence is .
-
How much funding has Genascence raised over time?
Genascence has raised $10.5M.
-
Who are Genascence’s investors?
California Institute for Regenerative Medicine, United States Department of War, Deepwork Capital, Pacira BioSciences, and University of Florida Research Foundation are 5 of 7 investors who have invested in Genascence.
-
Who are Genascence’s competitors?
Xalud Therapeutics, Alexion, Centrexion Therapeutics, NGM Biopharmaceuticals, and Artax Biopharma are some of the 23 competitors of Genascence.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process